Results 31 to 40 of about 10,145,629 (294)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression

open access: yesBrain Sciences, 2023
Psychotic treatment-resistant depression is a complex and challenging manifestation of mood disorders in the clinical setting. Psychotic depression is a subtype of major depressive disorder characterized by mood-consistent hallucinations and/or delusions.
Maria Gałuszko-Węgielnik   +4 more
doaj   +1 more source

Metacognitive Therapy in Treatment-Resistant Psychosis:A Multiple-Baseline Study [PDF]

open access: yes, 2013
Background: More effective psychological treatments for psychosis are required. Case series data and pilot trials suggest metacognitive therapy (MCT) is a promising treatment for anxiety and depression.
Wardle, Melissa   +8 more
core   +1 more source

Acute Onset of Suicidal Ideation after Starting Lemborexant in a Patient with a Mood Disorder

open access: yesSleep Science
A 24-year-old woman with treatment-resistant depressive symptoms and chronic insomnia developed acute, intrusive suicidal ideation with intent on day 5 after starting lemborexant 10 mg nightly.
Renato Rodrigo Silva   +3 more
doaj   +1 more source

Antidepressant discontinuation in treatment resistant depression

open access: yesContemporary Clinical Trials Communications, 2019
Treatment-resistant depression (TRD) is a growing problem in psychiatric practice with some 15–20% of depressed patients becoming chronically depressed and perhaps as many as 40% in tertiary settings.
Ziad A. Ali   +2 more
doaj   +1 more source

Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit? [PDF]

open access: yes, 2011
Sarah E Hetrick1, Georgina R Cox1, Sally N Merry21Orygen Youth Health Research Centre, Centre for Youth Mental Health, Melbourne, Parkville, Victoria, Australia; 2Werry Centre for Child and Adolescent Mental Health, Department of Psychological Medicine ...
Cox, GR   +8 more
core   +1 more source

Opioid agents for treatment-resistant depression

open access: yes, 2022
Treatment-resistant depression (TRD) is a major public health problem in terms of prevalence, individual suffering, and cost for society, and it is commonly associated with significant disability and psychosocial impairment worldwide.
Amerio A.   +5 more
core   +1 more source

Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment‐resistant depression

open access: yesNeuropsychopharmacology Reports, 2021
Aim Approximately one‐third of patients with major depressive disorder develop treatment‐resistant depression. One‐third of patients with treatment‐resistant depression demonstrate resistance to ketamine, which is a novel antidepressant effective for ...
Tomoyuki Nakamura   +7 more
doaj   +1 more source

Neuromodulation for treatment-resistant depression [PDF]

open access: yesF1000 Medicine Reports, 2012
Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial direct current stimulation, magnetic seizure therapy,
Holtzheimer, Paul E., Mayberg, Helen S.
openaire   +2 more sources

The heterodimeric amino acid transporters (HAT) of the SLC7/SLC3 family: A structure−function relationships and relevance to human pathology

open access: yesFEBS Letters, EarlyView.
Heterodimeric amino acid transporters consist of SLC7 and SLC3 family proteins arranged in a conserved structural organization. They regulate nutrient transport across cell membranes, supporting essential cellular functions. These transporters also contribute to xenobiotic/drug uptake and distribution.
Mariafrancesca Scalise   +5 more
wiley   +1 more source

Treatment-resistant depression and its diagnosis and treatment

open access: yesSichuan jingshen weisheng, 2022
The aim of this study is to explore the diagnostic strategies and options for treatment-resistant depression (TRD). Despite the well-established efficacy of antidepressants, 20%~30% of depressive patients in the clinic fail to respond or respond poorly ...
Hu Shaohua
doaj   +1 more source

Home - About - Disclaimer - Privacy